These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3089411)

  • 1. Randomised trial of compliance with screening for colorectal cancer.
    Nichols S; Koch E; Lallemand RC; Heald RJ; Izzard L; Machin D; Mullee MA
    Br Med J (Clin Res Ed); 1986 Jul; 293(6539):107-10. PubMed ID: 3089411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient compliance with colorectal cancer screening in general practice.
    Mant D; Fuller A; Northover J; Astrop P; Chivers A; Crockett A; Clements S; Lawrence M
    Br J Gen Pract; 1992 Jan; 42(354):18-20. PubMed ID: 1586526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of general practitioners in mass screening. Experience of a colorectal cancer mass screening programme in the Calvados region (France).
    Launoy G; Veret JL; Richir B; Reaud JM; Ollivier V; Valla A; Gignoux M
    Eur J Cancer Prev; 1993 May; 2(3):229-32. PubMed ID: 8490541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for asymptomatic bowel cancer in general practice.
    Lallemand RC; Vakil PA; Pearson P; Box V
    Br Med J (Clin Res Ed); 1984 Jan; 288(6410):31-3. PubMed ID: 6418307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting compliance in colorectal cancer screening. Results of a study performed in Ballarat.
    Macrae FA; St John DJ; Ambikapathy A; Sharpe K; Garner JF
    Med J Aust; 1986 Jun; 144(12):621-3. PubMed ID: 3713601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload.
    Pye G; Christie M; Chamberlain JO; Moss SM; Hardcastle JD
    J Epidemiol Community Health; 1988 Mar; 42(1):66-71. PubMed ID: 3418289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intervention in large bowel carcinogenesis--does screening improve prognosis?
    Farrands PA; Britton DC
    Scand J Gastroenterol Suppl; 1984; 104():151-9. PubMed ID: 6597547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests.
    Thomas WM; Pye G; Hardcastle JD; Mangham CM
    Br J Surg; 1990 Mar; 77(3):277-9. PubMed ID: 2322789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal carcinoma: an analysis of the sensitivity of haemoccult.
    Thomas WM; Pye G; Hardcastle JD; Walker AR
    Br J Surg; 1992 Aug; 79(8):833-5. PubMed ID: 1393487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study.
    Faivre J; Arveux P; Milan C; Durand G; Lamour J; Bedenne L
    Eur J Cancer Prev; 1991 Oct; 1(1):49-55. PubMed ID: 1842684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial.
    Verne J; Kettner J; Mant D; Farmer A; Mortenson N; Northover J
    Eur J Cancer Prev; 1993 Jul; 2(4):301-5. PubMed ID: 8358281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for large bowel neoplasms in individuals with a family history of colorectal cancer.
    Dunlop MG
    Br J Surg; 1992 Jun; 79(6):488-94. PubMed ID: 1611436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
    Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood donor centres can effectively publicise cancer screening.
    Hart AR; Jestico B; Antill C; Taylor M; Mayberry JF
    Public Health; 1996 Jul; 110(4):247-9. PubMed ID: 8757707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England.
    Hart AR; Barone TL; Gay SP; Inglis A; Griffin L; Tallon CA; Mayberry JF
    J Epidemiol Community Health; 1997 Apr; 51(2):187-91. PubMed ID: 9196650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An industry based approach to colorectal cancer screening in an asymptomatic population.
    Hart AR; Glover N; Howick-Baker J; Mayberry JF
    Postgrad Med J; 2003 Nov; 79(937):646-9. PubMed ID: 14654576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance.
    Robinson MH; Pye G; Thomas WM; Hardcastle JD; Mangham CM
    Eur J Surg Oncol; 1994 Oct; 20(5):545-8. PubMed ID: 7926056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme.
    Hart AR; Eaden J; Barnett S; de Bono AM; Mayberry JF
    J Epidemiol Community Health; 1998 Dec; 52(12):818-20. PubMed ID: 10396524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test.
    Adamsen S; Kronborg O
    Scand J Gastroenterol; 1984 Jun; 19(4):531-4. PubMed ID: 6463577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.